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rs2071045, in the intron_2 region, +909 start codon) of the LEP in
Chinese Han populations.
Methods: The 3 tag SNPs of LEP were genotyped in patients who
had primary symptomatic knee OA with radiographic conﬁrmation and in
matched controls, and the association was examined. A total of 719 OA
patients and 699 controls were genotyped. We performed a Chi-square
test in this case-control study.
Results: No signiﬁcant difference was detected in genotypes, allele fre-
quencies or haplotypes between knee OA and control groups in Chinese
Han populations (all P> 0.05). Association was not observed even after
stratiﬁcation by gender and Kellgren/Lawrence (K/L) scores.
Conclusions: Our results suggest that there is no association between
LEP and knee OA. However, lack of association should be concluded by
further replication studies.
367 GENETIC VARIATION IN THE GDF5-UQCC REGION IS
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Purpose: A polymorphism (rs143383) near the GDF-5 gene has previ-
ously been associated with height, hip and knee osteoarthritis, but debate
exists whether its primary biological action is directed to cartilage or bone.
Although GDF-5 mutations result in many skeletal syndromes, they seem
to have in common that limb, and more in particular hand abnormalities
are present. We studied the association between genetic variation in
the GDF-5-UQCC region and height, radiographic osteoarthritis (ROA)
susceptibility at the hand, knee and hip, bone parameters and fracture
risk in a large population-based cohort.
Methods: In total, 6,365 participants from the Rotterdam Study had
genotype data available for 32b tagging SNPs spanning the GDF5-
UQCC region (400 kb). ROA was deﬁned using a Kellgren/Lawrence (K/L)
score 2 for three different joint sites (hand, knee and hip). BMD was
measured at the hip and lumbar spine using DEXA and incident fractures
were assessed during a mean follow-up time of 7 years.
Results: We observed the rs143383 and three highly correlated SNPs in
the GDF5-UQCC region to be associated with height and osteoarthritis
in women. Female homozygote carriers of the rs143383 C-allele were
1.1 cm taller than women with the TT-genotype (plinear = 0.001). Female
carriers of the C-allele were at a lower risk for both hand OA (OR 0.63,
p = 8×10−6) and knee OA (OR: 0.72, p = 0.003) than women with the TT-
genotype. These association did not change when adjustments for age
and height were made. The population attributable risk for the rs143383
was 11% for hand OA and 8.5% for knee OA. No associations with
hip OA were detected with any SNP in the GDF5-UQCC region. The
CC-genotype in women was also associated with an increased risk of
incident nonvertebral fractures (Hazard Ratio: 1.29, p = 0.02) compared
with the TT-genotype. All associations were independent. No association
was found with bone mineral density or bone geometry. No signiﬁcant
differences were observed in men.
Conclusions: This study shows that genetic variation in the GDF-5-
UQCC region is associated with height, hand OA, knee OA, and fracture
risk in elderly women. All these associations seem to be independent of
each other. We do not see an association in men. This could be due to
lower power in men, or alternatively, it could be that sex-speciﬁc hormones
(like androgens and estrogens) might be involved in the regulation of
GDF-5. This has been shown for BMP6, a closely related growth factor.
This is the ﬁrst population-based cohort showing an association with
hand-OA and fracture risk. The risk for hand OA attributable to the GDF5
polymorphism is 11% within women in our population, which is in the
same order of magnitude as the population attributable risk for having an
age above 70 years in this population (PAR=20%).
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Purpose: Previous studies have suggested that inﬂammation may be
important in the pathogenesis and progression of generalized OA (GOA).
We performed a study comparing subjects having knee OA with those
having knee and hand OA (GOA) to investigate if selected candidate
genetic polymorphisms were associated with GOA.
Methods: One hundred forty-four OA patients (81 knee OA and 63 GOA)
from two separate study center databases (NYUHJD, N=94 and Duke,
N=50) met inclusion criteria in this retrospective analysis. Caucasians of
either sex, free of chronic disease, with a radiographic diagnosis of knee
OA or GOA were genotyped for single nucleotide polymorphisms (SNPs).
These subjects were divided into two groups: knee OA and GOA. We
performed statistical analysis using Chi square and logistic regression,
adjusting for age, gender and BMI to search for associations of GOA with
individual SNPs and with haplotypes.
Results: After adjustment for age, gender, and BMI, individual TNF-a, IL1,
IL1 receptor antagonist (IL1RN) SNPs were strongly associated with GOA
(Table 1). In three of the four SNPs, alleles associated with increased
incidence of GOA have been previously associated with increased in-
ﬂammatory mediators. These alleles are: IL1B (−3737) rs4848306 TT/CT,
IL1B (−511) rs16944 CC/CT, and TNF-a (−308) rs1800629 AA/AG. The
association of IL1RN rs315952 with inﬂammatory mediators has not been
characterized.
Conclusions: Among those with OA, individual TNFa, IL1B, and IL1RN
SNPs are associated with an increased prevalence of GOA. These
genetic markers are likely to be useful in predicting which early OA
patients have a greater chance to develop GOA. Ongoing research will
attempt to link inﬂammatory genotypes with in vitro production of cytokine
mRNAs by peripheral blood mononuclear cells.
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Purpose: Osteoclastogenesis is controlled by the ratio of receptor ac-
tivator of NF-kappaB ligand (RANKL) relative to its decoy receptor,
osteoprotegerin (OPG). Recent studies have shown that OPG, sRANKL
and sRANKL/OPG are increased in osteoarthritis patients’ serum and
synovium and associated with radiographic severity of knee OA. We
have also previously shown modest associations between OPG genetic
variants and knee OA. In this study we explored whether a polymorphism
rs4355801, which maps 12 kb 5′ from the OPG gene and is associated
with osteoprotegerin expression levels and bone density, was also asso-
ciated with incidence of knee OA.
Methods: Study subjects (n = 908) were derived from the Chingford study,
which is a population-based longitudinal cohort of Caucasian women
recruited from Chingford, London since 1989 aged 43 to 67 years at
onset (mean 53.8, SD=+6.0 year). Tibiofemoral disease was assessed
using the Kellgren-Lawrence (KL) radiographic score, as well as individual
grading for osteophytes and joint space narrowing (JSN) of medial and
lateral compartments. Cases of radiographic knee OA (n = 187) were
deﬁned as subjects with individual features absent in year 1 and with
a KL score 2 in year 10, Controls were subjects with no features at
both years 1 and 10 (n = 721). Analyses were performed using logistic
regression modeling with age and Body Mass Index as covariates.
Results: We found that rs4355801 showed a trend for association with
incidence of radiographic KL score and signiﬁcant association with inci-
dence of osteophytes (OR up to 1.81 with p< 0.01). No association was
found with JSN.
Conclusions: Our results indicate that genetic variation associated with
OPG levels is also implicated in the pathogenesis of knee osteoarthritis.
These data are consistent with previous studies which showed that OPG
serum levels are associated with severity of knee OA. Because OPG
is a regulator of bone resorption we hypothesize it mainly acts through
bone re-modeling rather than cartilage degeneration. The involvement of
OPG in the pathogenesis of both osteoarthritis and osteoporosis suggests
that OPG may be a suitable target for therapeutic intervention for both
diseases, as well as a potential prognostic indicator.
